These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15371919)

  • 1. Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection.
    Wambura C; Aoyama N; Shirasaka D; Kuroda K; Maekawa S; Ebara S; Watanabe Y; Tamura T; Kasuga M
    Eur J Gastroenterol Hepatol; 2004 Oct; 16(10):969-79. PubMed ID: 15371919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection.
    McCarthy CJ; Crofford LJ; Greenson J; Scheiman JM
    Am J Gastroenterol; 1999 May; 94(5):1218-23. PubMed ID: 10235197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.
    Ohkusa T; Fujiki K; Takashimizu I; Kumagai J; Tanizawa T; Eishi Y; Yokoyama T; Watanabe M
    Ann Intern Med; 2001 Mar; 134(5):380-6. PubMed ID: 11242498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
    Miyake K; Tatsuguchi A; Suzuki K; Ueki N; Shinji Y; Kusunoki M; Iizumi T; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Tsukui T; Sakamoto C
    Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
    Kokkola A; Sipponen P; Rautelin H; Härkönen M; Kosunen TU; Haapiainen R; Puolakkainen P
    Aliment Pharmacol Ther; 2002 Mar; 16(3):515-20. PubMed ID: 11876705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    Marusic M; Babic Z; Nesanovic M; Lucijanic-Mlinac M; Stajcar V
    World J Gastroenterol; 2005 Apr; 11(15):2334-6. PubMed ID: 15818748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
    Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
    Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
    Fischer H; Huber V; Boknik P; Luess H; Neumann J; Schmitz W; Domschke W; Konturek JW
    Microsc Res Tech; 2001 Jun; 53(5):336-42. PubMed ID: 11376494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
    Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
    Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
    Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
    Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
    J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
    Geboes K; Dekker W; Mulder CJ; Nusteling K;
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1819-26. PubMed ID: 11683696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
    Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
    Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a proton pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.
    Suzuki M; Suzuki H; Kitahora T; Miyazawa M; Nagahashi S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2002 Jan; 16(1):159-65. PubMed ID: 11856091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients.
    Zerbib F; Lenk C; Sawan B; Cayla R; Broutet N; Carles B; de Mascarel A; Mégraud F; Lamouliatte H
    Eur J Gastroenterol Hepatol; 2000 Jul; 12(7):719-25. PubMed ID: 10929896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
    Sung JJ; Leung WK; Go MY; To KF; Cheng AS; Ng EK; Chan FK
    Am J Pathol; 2000 Sep; 157(3):729-35. PubMed ID: 10980112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.